Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dolby Laboratories Inc shares valued at $304,036 were sold by SHERMAN MARK ANDREW on Dec 01 ’25. At $67.56 per share, SHERMAN MARK ANDREW sold 4,500 shares. The insider’s holdings dropped to 62,397 shares worth approximately $4.12 million following the completion of this transaction.
Also, MARK ANDREW SHERMAN purchased 4,500 shares, netting a total of over 304,036 in proceeds.
Before that, YEAMAN KEVIN J had sold 36,699 shares from its account. In a trade valued at $2,455,405, the President and CEO traded Dolby Laboratories Inc shares for $66.91 each. Upon closing the transaction, the insider’s holdings decreased to 36,699 shares, worth approximately $7.58 million.
As published in their initiating research note from Robert W. Baird on September 05, 2025, Dolby Laboratories Inc [DLB] has been a Neutral and the price target has been revised to $74. As of June 03, 2024, Barrington Research has increased its “Mkt perform” rating to a “an Outperform” for DLB. Earlier on November 18, 2022, Barrington Research downgraded its rating. Their new recommendation was “a Mkt perform” for DLB stock which previously was a “an Outperform”.
Analyzing DLB Stock Performance
On last trading session, Dolby Laboratories Inc [NYSE: DLB] plunged -0.33% to $66.07. The stock’s lowest price that day was $65.9, but it reached a high of $66.835 in the same session. During the last five days, there has been a drop of approximately -1.39%. Over the course of the year, Dolby Laboratories Inc shares have dropped approximately -17.89%. Shares of the company reached a 52-week high of $89.66 on 01/30/25 and a 52-week low of $64.02 on 11/18/25.
Support And Resistance Levels for Dolby Laboratories Inc (DLB)
According to the 24-hour chart, there is a support level at 65.69, which, if violated, would cause prices to drop to 65.32. In the upper region, resistance lies at 66.65. The next price resistance is at 67.24. RSI (Relative Strength Index) is 45.87 on the 14-day chart, showing neutral technical sentiment.
Is Dolby Laboratories Inc subject to short interest?
Stocks of Dolby Laboratories Inc saw a sharp rise in short interest on 2025-11-14 jumping by 0.48 million shares to 2.65 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 2.18 million shares. A jump of 17.97% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.16 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.16.
Which companies own the most shares of Dolby Laboratories Inc (DLB)?
In terms of Dolby Laboratories Inc share price expectations, FactSet research, analysts set an average price target of 79.5 in the next 12 months, up nearly 19.93% from the previous closing price of $66.29. Analysts anticipate Dolby Laboratories Inc stock to reach 85 by 2025, with the lowest price target being 74. In spite of this, 2 analysts ranked Dolby Laboratories Inc stock as Buy at the end of 2025. On May 24, 2022, Rosenblatt assigned a price target of “a Buy” to the stock and initiated coverage with a $90.
